Brookline Capital Acquisition Corp. (BCAC) Research

Brookline Capital Acquisition Corp., established in New York in 2020, currently maintains no active business operations. Instead, its primary objective is to complete a strategic business combination, such as a merger, asset acquisition, or stock purchase, with an existing company. The company specifically targets opportunities within the life sciences industry.

Market snapshot

Symbol
BCAC
Price
$22.71
Day change
+127.33%
Market cap
$559.6M
P/E ratio
-462.65x
Sector
Financial Services
Industry
Shell Companies

Peer companies

  • Ares Acquisition Corporation II (AACT)
  • African Gold Acquisition Corporation (AGAC)
  • CM Life Sciences II Inc. (CMII)
  • Decarbonization Plus Acquisition Corporation IV (DCRD)
  • Helix Acquisition Corp. (HLXA)
  • Rice Acquisition Corp. II (RONI)
  • Sagaliam Acquisition Corp. (SAGA)
  • Trine II Acquisition Corp. (TRAQ)

Recent insider activity

  • GLAZER CAPITAL, LLC — S-Sale (400000 shares) on 2021-02-11
  • GLAZER CAPITAL, LLC — trade (0 shares) on 2021-01-29
  • Serafini Tito — trade (0 shares) on 2021-01-28
  • Xu Peixin — P-Purchase (39375 shares) on 2017-06-28
  • Xu Peixin — P-Purchase (39375 shares) on 2017-06-28

Open Brookline Capital Acquisition Corp. (BCAC) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.